Tissue Regenix appointed Drew Distin as vice president of its recently established subsidiary, Tissue Regenix Orthopaedic, North America.
Spinal Tech
In January, Ladenburg Thalmann gave the Amedica shares a "buy" rating, according to Risers & Fallers.
MX Orthopedics received FDA clearance for its dynaMX Compression Staple.
There are two new economic publications showing the cost-effectiveness of minimally invasive sacroiliac joint fusion with SI-BONE's iFuse Implant System.
Stryker plans to acquire Synergetics USA's neuro portfolio.
Advertisement
Obtaining reimbursement for new spine surgery technology isn't a walk in the park. There are instances where a new technology receives FDA clearance, support from spine societies, a Category 1 CPT code and coverage by Medicare and Medicaid, and a…
Farmingdale, N.Y.-based Misonix released its financial results for the second quarter of fiscal year 2016, ending Dec. 31, 2015.
Northland Securities downgraded Alphatec Holdings' shares from an "outperform" rating to a "sell" rating on Feb. 9, according to The Vista Voice.
The global spinal trauma devices market is expected to grow due to an increasing number of traffic accidents, geriatric population and number of trauma care centers.
Analysts forecast NuVasive will report negative EPS growth for the fourth quarter of 2015, according to WallStreet.org.